To Evaluate Disease and Treatment Awareness, Self Medication Practices and Drugs Prescribed in Patients of Osteoporosis

Not Applicable

• Conditions: Health Condition 1: M810- Age-related osteoporosis without current pathological fracture

• Registration Number: CTRI/2024/05/067474
• Lead Sponsor: Dr Raakhi Tripathi

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 27 May 2024

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

attending Endocrinology OPD and Orthopaedic OPD and have already been receiving treatment for at least 1 month with confirmed diagnosis of Osteoporosis with or without comorbidities by treating physician.

Exclusion Criteria

1. Patients not willing to give informed consent

2. Patients admitted in IPD and emergency department

3. Newly diagnosed and treatment naive patients

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. The primary variable is percentage of patients stating yes for each item of the Disease <br/ ><br>and Treatment awareness questionnaire. <br/ ><br>2. Mean awareness score will be calculated <br/ ><br>3. Mean Awareness Score will be correlated with demographic factors (Age, gender, <br/ ><br>occupation, education, and socio-economic status as per Kuppuswamy scale).Timepoint: As this is a cross-sectional survey, outcomes will be assessed at end of study,i.e, 18 months.

Secondary Outcome Measures

Name	Time	Method
Percentage of patients of Osteoporosis with or without <br/ ><br>comorbidities stating yes for each item of the self medication practice questionnaire using descriptive statisticsTimepoint: As this is a cross-sectional survey, outcomes will be assessed at end of study,i.e, 18 months.;To study the pattern of drugs used in the treatment of Osteoporosis .Timepoint: As this is a cross-sectional survey, outcomes will be assessed at end of study,i.e, 18 months.